• LISDEXAMFETAMINE CHEMBL1201222 FDA Approved

    Alternate Names:

    SCHEMBL158949
    Lisdexamfetamine
    (2S)-2,6-DIAMINO-N-[(2S)-1-PHENYLPROPAN-2-YL]HEXANIMIDIC ACID
    ZINC11680943
    VOBHXZCDAVEXEY-JSGCOSHPSA-N
    GTPL7213
    H645GUL8KJ
    D08130
    VYVANSEREG
    LS-187377
    DB01255
    LISDEXAMFETAMINE (INN)
    UNII-H645GUL8KJ
    VYVANSE
    11597698
    608137-32-2
    MOLPORT-004-285-960
    16700339
    11597697
    CID11597698
    DAP000571

    Drug Info:

    FDA Approval 2007
    Drug Class small molecule
    Drug Indications Central Nervous System Stimulants
    Year of Approval 2007
    Drug Class central nervous system stimulants
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    LISDEXAMFETAMINE Primary Drug Name

    Drug Info:
    Drug Class central nervous system stimulants
    Year of Approval 2007

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Central Nervous System Stimulants
    Drug Class small molecule
    FDA Approval 2007

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    608137-32-2 Drug Synonym
    LISDEXAMFETAMINE pubchem_primary_name
    11597698 PubChem CID

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    D08130 Drug Synonym
    LISDEXAMFETAMINE Primary Drug Name
    DB01255 Drug Synonym

    Drug Info:

    Publications: